Biomica CSO to Present at the ECCO 2023 Annual Meeting in Copenhagen between March 1-4, 2023
/PRNewswire/ -- Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Stay updated with breaking news from Virtual Congress Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Disc Medicine to Present at the European Hematology Association (EHA) 2021 Virtual Congress News provided by Share this article Share this article CAMBRIDGE, Mass., May 24, 2021 /PRNewswire/ -- Disc Medicine, a biotechnology company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, today announced that preclinical data of its hepcidin induction program will be presented at the upcoming European Hematology Association (EHA) 2021 Virtual Congress, which will be held from June 9-17. Details of the presentations are as ...